The latest closing stock price for ZyVersa Therapeutics as of May 28, 2025 is 0.57.
An investor who bought $1,000 worth of ZyVersa Therapeutics stock at the IPO in 2022 would have $-1,000 today, roughly -1 times their original investment - a -94.51% compound annual growth rate over 3 years.
The all-time high ZyVersa Therapeutics stock closing price was 7875.00 on December 12, 2022.
The ZyVersa Therapeutics 52-week high stock price is 6.30, which is 1005.3% above the current share price.
The ZyVersa Therapeutics 52-week low stock price is 0.47, which is 17.5% below the current share price.
The average ZyVersa Therapeutics stock price for the last 52 weeks is 1.98.
An investor who bought $1,000 worth of ZyVersa Therapeutics stock at the IPO in 2022 would have $-1,000 today, roughly -1 times their original investment - a -94.51% compound annual growth rate over 3 years.
The all-time high ZyVersa Therapeutics stock closing price was 7875.00 on December 12, 2022.
The ZyVersa Therapeutics 52-week high stock price is 6.30, which is 1005.3% above the current share price.
The ZyVersa Therapeutics 52-week low stock price is 0.47, which is 17.5% below the current share price.
The average ZyVersa Therapeutics stock price for the last 52 weeks is 1.98.